These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23355135)

  • 1. The role of implantable cardiac defibrillators in cardiac sarcoidosis: saviour or sinner?
    Heck PM; Roberts PR
    Europace; 2013 Mar; 15(3):309-10. PubMed ID: 23355135
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pursuing the "Holy Grail".
    Dickfeld T
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):167-70. PubMed ID: 22438421
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Obeyesekere regarding article, "Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death".
    Obeyesekere MN
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):e52; author reply e53. PubMed ID: 22811421
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
    Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual Incessant Ventricular Tachycardia: What Is the Underlying Cause and the Possible Mechanism?
    Shenthar J
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1507-11. PubMed ID: 26671936
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in implantable cardioverter-defibrillator therapy: Advancement beyond technology alone.
    Bhakta D; Foreman LD
    Trends Cardiovasc Med; 2015 Oct; 25(7):612-3. PubMed ID: 25776986
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable Cardioverter-Defibrillators and Wearable Defibrillators: Guidelines and Updates.
    Mathuria N
    Tex Heart Inst J; 2020 Feb; 47(1):51-52. PubMed ID: 32148457
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
    Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
    Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
    Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
    Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Sympathetic Denervation for the Treatment of Ventricular Arrhythmias: A Lesson in Not Throwing Out the Baby With the Bathwater?
    Reddy VY; Miller MA
    JACC Cardiovasc Interv; 2015 Jun; 8(7):991-3. PubMed ID: 26088517
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.
    Dhadham GC; Gupta N; Parikh R; Bikkina M
    Tex Heart Inst J; 2011; 38(1):74-6. PubMed ID: 21423476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device therapy: High-zone programming of ICDs reduces inappropriate shocks.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):193. PubMed ID: 25732361
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual substrate underlying Brugada syndrome and early repolarization syndrome revealed in unusual circadian and seasonal patterns.
    Schwartz BG; Kloner RA; Cannom DS
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):764-5. PubMed ID: 22487225
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.